Market Wizard
Super Duper Aggressive Short Term Call Buy FSC at CMP of 72.5 - 73 and dips till 69 Sl 67 Targets:- 74 - 75 - 76 - 77 - 78 - 79+ Above 79 we can see 82 - 85 - 88+ Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.…
FSC 75.75 ❤️
Upper Circuit locked 🔒
Upper Circuit locked 🔒
Mid Term Aggressive Call
Buy KKCL at CMP of 907 - 915 and dips till 800
Sl 790
Trading SL - 850
Targets:- Upto 930 - 938 - 950+
Above 950 we can see 1000 - 1100 - 1200 +
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Buy KKCL at CMP of 907 - 915 and dips till 800
Sl 790
Trading SL - 850
Targets:- Upto 930 - 938 - 950+
Above 950 we can see 1000 - 1100 - 1200 +
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Market Wizard
Mid Term Aggressive Call Buy KKCL at CMP of 907 - 915 and dips till 800 Sl 790 Trading SL - 850 Targets:- Upto 930 - 938 - 950+ Above 950 we can see 1000 - 1100 - 1200 + Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before…
KKCL Short Term targets done in 10 mins 😂😜
Mid or Long Term Quality Fundamental Call
Buy Triton Valves (Bse - 505978) at CMP of 1014 - 1025 and dips till 900
Sl 862
Targets:- 1050 - 1074 - 1104 - 1177 - 1250+
Above that we can see 1350 - 1500+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Buy Triton Valves (Bse - 505978) at CMP of 1014 - 1025 and dips till 900
Sl 862
Targets:- 1050 - 1074 - 1104 - 1177 - 1250+
Above that we can see 1350 - 1500+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Techno Funda Short Term Call
Buy HIMTEK (BSE - 505712) at CMP of 94.5 - 96 and dips till 89
Sl 84
Targets:- 100 - 102 - 104 - 107 - 110 - 113 - 117 - 120+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Buy HIMTEK (BSE - 505712) at CMP of 94.5 - 96 and dips till 89
Sl 84
Targets:- 100 - 102 - 104 - 107 - 110 - 113 - 117 - 120+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
SIGIND - 20%
INDOBORAX - 20%
INTENSE TECH - 20%
GOKUL AGRO - 20%
PDSML - 20%
TTK HEALTHCARE - 18%
TOKYO PLAST - 18%
NSIL - 13%
SUMEDHA - 18%
GPT INFRA 18%
SHREYAS SHIPPING - 10%
WHITE ORGANICS -10%
TIDE WATER - 10%
DCM - 10%
NDGL - 10%
KKCL - 12%
TRITON - 13%
STOCKS WHICH ARE UP MORE THAN 10%. 🔥🔥
POWER OF MARKET WIZARD RESEARCH. STOCKS WHICH ARE UP BUT LESS THAN 10% IS NOT INCLUDED HERE IN THIS LIST.
INDOBORAX - 20%
INTENSE TECH - 20%
GOKUL AGRO - 20%
PDSML - 20%
TTK HEALTHCARE - 18%
TOKYO PLAST - 18%
NSIL - 13%
SUMEDHA - 18%
GPT INFRA 18%
SHREYAS SHIPPING - 10%
WHITE ORGANICS -10%
TIDE WATER - 10%
DCM - 10%
NDGL - 10%
KKCL - 12%
TRITON - 13%
STOCKS WHICH ARE UP MORE THAN 10%. 🔥🔥
POWER OF MARKET WIZARD RESEARCH. STOCKS WHICH ARE UP BUT LESS THAN 10% IS NOT INCLUDED HERE IN THIS LIST.
Follow this link to join my WhatsApp group: https://chat.whatsapp.com/KUuI70RifSW7chXFiwwAMY
SHILPA MEDICARE: Q4 EBITDA RUPEES 262M VS 456M (YOY) | 210M (QOQ) || Q4 EBITDA MARGIN 12.6% VS 20.73% (YOY) | 10.96% (QOQ)
*Aurobindo Pharma Q4 First Cut – Ebitda and Ebitda margin ahead of expectation*
Q4 net profit Rs802cr (down 7.2% YoY) – expectation Rs732cr
Ebitda margin 21.2% VS 21.4% (YoY) – expectation 20.7%
Ebitda Rs1274.6cr (down 3.2% YoY) – expectation Rs1251cr
Income Rs6000cr (down 2.5% YoY) – expectation Rs6029.6cr
Q4 net profit Rs802cr (down 7.2% YoY) – expectation Rs732cr
Ebitda margin 21.2% VS 21.4% (YoY) – expectation 20.7%
Ebitda Rs1274.6cr (down 3.2% YoY) – expectation Rs1251cr
Income Rs6000cr (down 2.5% YoY) – expectation Rs6029.6cr
Ganesh Benzoplast, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
Jindal SAW declared highest ever quarterly sales and 461% higher net profit. It reduced debt in FY21 and interest cost fell to the lowest since FY14. This dark horse can give multi-bagger returns.
Some positive announcement is likely from Central Bank of India. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, IOL Chemicals & Pharmaceuticals is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
Maheshwari Logistics into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
Pennar Industries manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
Shemaroo recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver Signet Industries can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to Digispice Technologies (SPICE MONEY wallet) as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.
JK Tyre has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
Lemon Tree Hotels gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
Asian Tiles has given a technical breakout at Rs. 20
0 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360. t.me/TowerTalks
Jindal SAW declared highest ever quarterly sales and 461% higher net profit. It reduced debt in FY21 and interest cost fell to the lowest since FY14. This dark horse can give multi-bagger returns.
Some positive announcement is likely from Central Bank of India. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, IOL Chemicals & Pharmaceuticals is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
Maheshwari Logistics into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
Pennar Industries manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
Shemaroo recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver Signet Industries can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to Digispice Technologies (SPICE MONEY wallet) as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.
JK Tyre has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
Lemon Tree Hotels gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
Asian Tiles has given a technical breakout at Rs. 20
0 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360. t.me/TowerTalks
*Market Provisional closing*
*BSE SENSEX provisional close at 51,912.08 up 489.20 points or 0.95% vs Fri*
*NIFTY50 provisional close at 15,576.35 up 140.70 points or 0.91% vs Fri*
*BSE SENSEX provisional close at 51,912.08 up 489.20 points or 0.95% vs Fri*
*NIFTY50 provisional close at 15,576.35 up 140.70 points or 0.91% vs Fri*
🏦 Financial News Bulletin Dt.31st May,2021 forwarded by Allahabad Bank Employees' Union-APTS- affiliated to All India Bank Employees' Association (AIBEA)
The Government has decided to enlarge the scope of Emergency Credit Line Guarantee Scheme (ECLGS) by including support for onsite oxygen generation plants. Also, the civil aviation sector will now be eligible to avail the benefit of the scheme. The scheme provides 100% guarantee for loan by banks, financial institutions and NBFCs to eligible MSME and business entities beside MUDRA borrowers. Launched last year, the scheme has capped interest rate. It will provide guarantee up to total credit of Rs 3 lakh crore. As on date, 3 versions (ECLGS 1.0, 2.0 and 3.0) have been launched. “Under ECLGS 4.0, guarantee cover to loans up to Rs 2 crore will be provided to hospitals/nursing homes/clinics/medical colleges for setting up on-site oxygen generation plants,” a statement issued by the Finance Ministry said. The interest rate for such loan will be capped at interest rate capped at 7.5%.
-Business Line
Some modifications have been done in the previous versions of ECLGS. Borrowers of first version, who are eligible for restructuring as per RBI guidelines dated May 5, will now get will now get 5 years for repayment. This includes repayment of interest only for the first 24 months with repayment of principal and interest in next 36 months. Earlier, these borrowers were supposed to repay interest only during first 12 months and repayment of principal and interest in 36 months. In other words, such borrowers will get additional one year of moratorium on principal amount. These borrowers will also get additional ECLGS assistance of up to 10% of the outstanding as of February 29, 2020. It has also been decided to extend the validity of scheme to September 30 or guarantees for an amount of Rs.3 lakh crore are issued. Disbursement under the scheme permitted up to December 31.
-Business Line
As the government enhanced the scope of the Rs 3 lakh crore ECLGS, banks today said they have sanctioned Rs 2.54 lakh crore and have room to disburse another Rs 45,000 crore under the plan.
-Economic Times
Banks have decided to make available unsecured personal loans to individuals to meet the expenditure for Covid treatment. Further, they will also be extending loans to improve the healthcare infrastructure.
This is with a view to create, a Covid loan book as per RBI’s May 5 announcement that it will provide term liquidity facility of ₹50,000 crore to banks to ease access to Emergency Health Services. Individuals (salaries, non-salaried as well as pensioners) will be offered unsecured personal loans for Covid treatment of self and family members.The minimum and maximum amount of loan, which will be at a concessional rate and for a maximum period of 5 years, will be ₹25,000 and ₹5 lakh, respectively, said
Dinesh Khara, Chairman, SBI.
-Business Line
PSBs, under the aegis of the IBA, have formulated a templated approach for seamless implementation of RBI’s Resolution Framework 2.0 for restructuring loans to individuals, small business and MSMEs up to ₹25 crore. Banks have evolved a process flow for individual loans and a templated standardised approach for business and MSME loans up to ₹10 lakh.
-Business Line
Banks will be giving business loans for healthcare facilities. The target group for such loans will be the ecosystem engaged in building/servicing healthcare infrastructure; hospitals, nursing homes, clinics, diagnostic centres and pathology labs. The purpose of the business loans, which will be at a concessional rate and for a maximum period of 10 years, is to set up/expand healthcare infrastructure and to manufacture of healthcare products. The quantum of loans to be offered will be up to ₹100 crore at metro centres; up to ₹20 crore in Tier-I and urban centres; and up to ₹10 crore in Tier-II to Tier-VI centres. Rajkiran Rai G, Chairman, IBA, underscored that the Covid loan book will get priority sector classification.
The Government has decided to enlarge the scope of Emergency Credit Line Guarantee Scheme (ECLGS) by including support for onsite oxygen generation plants. Also, the civil aviation sector will now be eligible to avail the benefit of the scheme. The scheme provides 100% guarantee for loan by banks, financial institutions and NBFCs to eligible MSME and business entities beside MUDRA borrowers. Launched last year, the scheme has capped interest rate. It will provide guarantee up to total credit of Rs 3 lakh crore. As on date, 3 versions (ECLGS 1.0, 2.0 and 3.0) have been launched. “Under ECLGS 4.0, guarantee cover to loans up to Rs 2 crore will be provided to hospitals/nursing homes/clinics/medical colleges for setting up on-site oxygen generation plants,” a statement issued by the Finance Ministry said. The interest rate for such loan will be capped at interest rate capped at 7.5%.
-Business Line
Some modifications have been done in the previous versions of ECLGS. Borrowers of first version, who are eligible for restructuring as per RBI guidelines dated May 5, will now get will now get 5 years for repayment. This includes repayment of interest only for the first 24 months with repayment of principal and interest in next 36 months. Earlier, these borrowers were supposed to repay interest only during first 12 months and repayment of principal and interest in 36 months. In other words, such borrowers will get additional one year of moratorium on principal amount. These borrowers will also get additional ECLGS assistance of up to 10% of the outstanding as of February 29, 2020. It has also been decided to extend the validity of scheme to September 30 or guarantees for an amount of Rs.3 lakh crore are issued. Disbursement under the scheme permitted up to December 31.
-Business Line
As the government enhanced the scope of the Rs 3 lakh crore ECLGS, banks today said they have sanctioned Rs 2.54 lakh crore and have room to disburse another Rs 45,000 crore under the plan.
-Economic Times
Banks have decided to make available unsecured personal loans to individuals to meet the expenditure for Covid treatment. Further, they will also be extending loans to improve the healthcare infrastructure.
This is with a view to create, a Covid loan book as per RBI’s May 5 announcement that it will provide term liquidity facility of ₹50,000 crore to banks to ease access to Emergency Health Services. Individuals (salaries, non-salaried as well as pensioners) will be offered unsecured personal loans for Covid treatment of self and family members.The minimum and maximum amount of loan, which will be at a concessional rate and for a maximum period of 5 years, will be ₹25,000 and ₹5 lakh, respectively, said
Dinesh Khara, Chairman, SBI.
-Business Line
PSBs, under the aegis of the IBA, have formulated a templated approach for seamless implementation of RBI’s Resolution Framework 2.0 for restructuring loans to individuals, small business and MSMEs up to ₹25 crore. Banks have evolved a process flow for individual loans and a templated standardised approach for business and MSME loans up to ₹10 lakh.
-Business Line
Banks will be giving business loans for healthcare facilities. The target group for such loans will be the ecosystem engaged in building/servicing healthcare infrastructure; hospitals, nursing homes, clinics, diagnostic centres and pathology labs. The purpose of the business loans, which will be at a concessional rate and for a maximum period of 10 years, is to set up/expand healthcare infrastructure and to manufacture of healthcare products. The quantum of loans to be offered will be up to ₹100 crore at metro centres; up to ₹20 crore in Tier-I and urban centres; and up to ₹10 crore in Tier-II to Tier-VI centres. Rajkiran Rai G, Chairman, IBA, underscored that the Covid loan book will get priority sector classification.